455
Views
19
CrossRef citations to date
0
Altmetric
Review Article

Real-world challenges for hepatitis C virus medications: a critical overview

, , &
Pages 143-160 | Received 01 Jan 2017, Accepted 08 May 2017, Published online: 25 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Isra Umbreen Mufti, Muhammad Sufyan, Imran Shahid, Abdullah R. Alzahrani, Naiyer Shahzad, Ibrahim Mufadhi M. Alanazi, Ibrahim Abdel Aziz Ibrahim & Sidra Rehman. Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now

Articles from other publishers (18)

Ping‐Hung Ko, Chih‐Wei Tseng, Kuo‐Chih Tseng, Yen‐Chun Chen & Ching‐Sheng Hsu. (2022) The utility of HCV core antigen for evaluation of viremia at 48 weeks posttreatment with direct‐acting antivirals . Advances in Digestive Medicine 10:2, pages 80-86.
Crossref
Toshifumi Sato, Kimberly Z. Head, Jiang Li, Christine E. Dolin, Daniel Wilkey, Nolan Skirtich, Katelyn Smith, Dylan D. McCreary, Sylvia Liu, Juliane I. Beier, Aatur D. Singhi, Ryan M. McEnaney, Michael L. Merchant & Gavin E. Arteel. (2023) Fibrosis resolution in the mouse liver: Role of Mmp12 and potential role of calpain 1/2. Matrix Biology Plus 17, pages 100127.
Crossref
Imran Shahid & Qaiser JabeenImran Shahid & Qaiser Jabeen. 2023. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives 290 342 .
Imran Shahid & Qaiser JabeenImran Shahid & Qaiser Jabeen. 2023. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives 231 289 .
Imran Shahid & Qaiser JabeenImran Shahid & Qaiser Jabeen. 2023. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives 203 230 .
Imran Shahid & Qaiser JabeenImran Shahid & Qaiser Jabeen. 2023. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives 142 174 .
Imran Shahid & Qaiser JabeenImran Shahid & Qaiser Jabeen. 2023. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives 54 71 .
Imran Shahid & Qaiser JabeenImran Shahid & Qaiser Jabeen. 2023. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives 26 53 .
Majed A. Algarni. (2022) Evaluating Post-Market Adverse Events of The New Hepatitis C Therapies Using FEARS Data. Healthcare 10:8, pages 1400.
Crossref
Meng Hsuan Kuo, Chih-Wei Tseng, Chi-Hui Lee, Ya-Ching Yang, Hsin-Ju Wu, Hsiu-Ju Lin, Ya-Lan Chu, Yen-Chun Chen & Kuo-Chih Tseng. (2022) Identification and management of contraindicated drug–drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy. Journal of the Formosan Medical Association 121:1, pages 58-65.
Crossref
Imran Shahid. (2021) Meet our Associate Editorial Board Member. Reviews on Recent Clinical Trials 16:2, pages 121-121.
Crossref
Daniel W. Kneller, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Leighton Coates & Andrey Kovalevsky. (2021) Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography. Journal of Medicinal Chemistry 64:8, pages 4991-5000.
Crossref
Ivan Alekseevich Akimov, D. I. Timofeev, A. R. Mavzyutov & M. K. Ivanov. (2021) Detection of circulating HCV recombinant form RF1_2k/1b in blood serum of patients by real-time RT-PCR. Russian Clinical Laboratory Diagnostics 66:2, pages 122-128.
Crossref
. (2019) UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 7:S8, pages 189-1030.
Crossref
Takumi Kawaguchi, Atsumasa Komori, Kunio Fujisaki, Shuhei Nishiguchi, Michio Kato, Hitoshi Takagi, Yasuhito Tanaka, Kazuo Notsumata, Eiji Mita, Hideyuki Nomura, Mitsushige Shibatoge, Koichi Takaguchi, Toshihiro Hattori, Michio Sata & Kazuhiko Koike. (2019) Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV‑infected patients with chronic liver disease and thrombocytopenia. Experimental and Therapeutic Medicine.
Crossref
Imran Shahid. 2018. Hepatitis C - From Infection to Cure. Hepatitis C - From Infection to Cure.
Imran Shahid, Munjed Mahmoud Ibrahim, Muhammad Usman Nawaz, Mohammad Tarque Imam & Waleed H. AlMalki. 2018. Genotyping. Genotyping.
Haijian Tu, Kun Lin, Yongzhi Lun & Liuming Yu. (2018) Magnetic bead/capture DNA/glucose-loaded nanoliposomes for amplifying the glucometer signal in the rapid screening of hepatitis C virus RNA. Analytical and Bioanalytical Chemistry 410:16, pages 3661-3669.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.